Mustafa Karabulut, Sevgi Kutlu, Wolfgang Viechtbauer, Ali Melliti, Cem Meço, Alfarghal Mohamad, Osman Nuri Özgirgin, Anita Bhandari, Herman Kingma, Raymond van de Berg
{"title":"Co-occurrence of otologic disorders and benign paroxysmal positional vertigo: Systematic review and meta-analysis.","authors":"Mustafa Karabulut, Sevgi Kutlu, Wolfgang Viechtbauer, Ali Melliti, Cem Meço, Alfarghal Mohamad, Osman Nuri Özgirgin, Anita Bhandari, Herman Kingma, Raymond van de Berg","doi":"10.21053/ceo.2025-00030","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To systematically investigate the co-occurrence of otologic disorders and benign paroxysmal positional vertigo (BPPV).</p><p><strong>Data sources: </strong>PubMed and Web of Science.</p><p><strong>Review methods: </strong>All original studies in English, from full-text clinical trials to case reports, involving participants ≥18 years old, were included. Two groups of article were identified: Group 1) studies reporting co-occurring otologic disorders in BPPV patients; Group 2) studies reporting co-occurring BPPV in patients with otologic disorders. The frequency of each condition was analyzed using descriptive statistics. Meta-analyses were performed using a random-effects model to estimate overall prevalence in both groups.</p><p><strong>Results: </strong>A total of 3407 studies were retrieved of which 68 articles were included in the analysis. In Group 1, 11.4% of BPPV patients (932/8157) had co-occurring otologic disorders (19 studies). The most commonly reported conditions were sudden sensorineural hearing loss (11.9%) and acute unilateral vestibulopathy/vestibular neuritis (5.0%). Meta-analyses showed pooled prevalences of 11.8% (95% CI: 3.1%- 35.7%) for sudden sensorineural hearing loss and 6.5% (95% CI: 3.7%-11.2%) for acute unilataral vestibulopathy/vestibular neuritis. In Group 2, 9.7% of patients with otologic disorders (1106/11457) had co-occurring BPPV (49 studies). Menière's disease was the most frequently reported disorder that resulted in co-occurring BPPV (10.2%). Meta-analyses showed pooled prevalences of 10.4% (95% CI: 6.2%-16.8%) for acute unilateral vestibulopathy/vestibular neuritis and 9.1% (95% CI: 4%-19.1%) for Menière's disease.</p><p><strong>Conclusion: </strong>The co-occurrence of otologic disorders and BPPV are prevalent. These findings demonstrate the need for mutual screening of BPPV and otologic disorders. Furthermore, these findings might help understanding the etiologies underlying BPPV.</p>","PeriodicalId":10318,"journal":{"name":"Clinical and Experimental Otorhinolaryngology","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Otorhinolaryngology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21053/ceo.2025-00030","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To systematically investigate the co-occurrence of otologic disorders and benign paroxysmal positional vertigo (BPPV).
Data sources: PubMed and Web of Science.
Review methods: All original studies in English, from full-text clinical trials to case reports, involving participants ≥18 years old, were included. Two groups of article were identified: Group 1) studies reporting co-occurring otologic disorders in BPPV patients; Group 2) studies reporting co-occurring BPPV in patients with otologic disorders. The frequency of each condition was analyzed using descriptive statistics. Meta-analyses were performed using a random-effects model to estimate overall prevalence in both groups.
Results: A total of 3407 studies were retrieved of which 68 articles were included in the analysis. In Group 1, 11.4% of BPPV patients (932/8157) had co-occurring otologic disorders (19 studies). The most commonly reported conditions were sudden sensorineural hearing loss (11.9%) and acute unilateral vestibulopathy/vestibular neuritis (5.0%). Meta-analyses showed pooled prevalences of 11.8% (95% CI: 3.1%- 35.7%) for sudden sensorineural hearing loss and 6.5% (95% CI: 3.7%-11.2%) for acute unilataral vestibulopathy/vestibular neuritis. In Group 2, 9.7% of patients with otologic disorders (1106/11457) had co-occurring BPPV (49 studies). Menière's disease was the most frequently reported disorder that resulted in co-occurring BPPV (10.2%). Meta-analyses showed pooled prevalences of 10.4% (95% CI: 6.2%-16.8%) for acute unilateral vestibulopathy/vestibular neuritis and 9.1% (95% CI: 4%-19.1%) for Menière's disease.
Conclusion: The co-occurrence of otologic disorders and BPPV are prevalent. These findings demonstrate the need for mutual screening of BPPV and otologic disorders. Furthermore, these findings might help understanding the etiologies underlying BPPV.
期刊介绍:
Clinical and Experimental Otorhinolaryngology (Clin Exp Otorhinolaryngol, CEO) is an international peer-reviewed journal on recent developments in diagnosis and treatment of otorhinolaryngology-head and neck surgery and dedicated to the advancement of patient care in ear, nose, throat, head, and neck disorders. This journal publishes original articles relating to both clinical and basic researches, reviews, and clinical trials, encompassing the whole topics of otorhinolaryngology-head and neck surgery.
CEO was first issued in 2008 and this journal is published in English four times (the last day of February, May, August, and November) per year by the Korean Society of Otorhinolaryngology-Head and Neck Surgery. The Journal aims at publishing evidence-based, scientifically written articles from different disciplines of otorhinolaryngology field.
The readership contains clinical/basic research into current practice in otorhinolaryngology, audiology, speech pathology, head and neck oncology, plastic and reconstructive surgery. The readers are otolaryngologists, head and neck surgeons and oncologists, audiologists, and speech pathologists.